Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.

There is evidence from cytogenetic and loss of heterozygosity studies for the involvement of a tumor suppressor gene on chromosome 22 in the formation of meningiomas. Recently, the NF2 gene, which causes neurofibromatosis type 2 and which is located in the affected region on chromosome 22, has been identified. A previous study on 8 of the 17 exons of the NF2 gene described mutations in 16% of meningiomas. We have analyzed the entire coding region of the NF2 gene in 70 sporadic meningiomas and identified 43 mutations in 41 patients. These resulted predominantly in immediate truncation, splicing abnormalities, or an altered reading frame of the predicted protein product. Although there was no evidence for distinct hotspots, all mutations occurred in the first 13 exons, the region of homology with the filopodial proteins moesin, ezrin, and radixin. The association of loss of heterozygosity on chromosome 22 with mutations in the NF2 gene was significant. These data suggest that NF2 represents the meningioma locus on chromosome 22. NF2 mutations occurred significantly more frequently in fibroblastic meningioma (70%) and transitional meningioma (83%) than in meningiothelial meningioma (25%), thus indicating a differential molecular pathogenesis of these meningioma variants.

[1]  A. Hagemeijer,et al.  Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. , 1994, American journal of human genetics.

[2]  J. Gusella,et al.  Exon scanning for mutation of the NF2 gene in schwannomas. , 1994, Human molecular genetics.

[3]  A. von Deimling,et al.  A device for processing large acrylamide gels. , 1994, BioTechniques.

[4]  V. P. Collins,et al.  Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression , 1994, International journal of cancer.

[5]  Olivier Delattre,et al.  Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas , 1994, Nature Genetics.

[6]  M. Sanson,et al.  The neurofibromatosis type 2 gene is inactivated in schwannomas. , 1994, Human molecular genetics.

[7]  D. Louis,et al.  A rapid and non‐radioactive PCR based assay for the detection of allelic loss in human gliomas , 1993, Neuropathology and applied neurobiology.

[8]  S. Pulst,et al.  Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 , 1993, Nature.

[9]  J. Haines,et al.  A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor , 1993, Cell.

[10]  B. Scheithauer,et al.  Histological Typing of Tumours of the Central Nervous System , 1993, World Health Organization.

[11]  D. Louis,et al.  A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens. , 1992, The American journal of pathology.

[12]  K. Hayashi,et al.  PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. , 1991, PCR methods and applications.

[13]  Jörg Schmidtke,et al.  Report of the DNA committee and catalogues of cloned and mapped genes, markers formatted for PCR and DNA polymorphisms , 1991 .

[14]  B Budowle,et al.  Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. , 1991, American journal of human genetics.

[15]  V. P. Collins,et al.  Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. , 1990, Cancer research.

[16]  V. P. Collins,et al.  Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Haines,et al.  Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22 , 1987, Nature.

[18]  R. Martuza,et al.  Molecular genetic approach to human meningioma: loss of genes on chromosome 22. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. A. Thomas,et al.  Molecular cloning. , 1977, Advances in pathobiology.